サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1785846

生検ガイダンスシステムの世界市場

Biopsy Guidance Systems

出版日
ページ情報
英文 273 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.90円
生検ガイダンスシステムの世界市場
出版日: 2025年08月07日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 273 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

生検ガイダンスシステムの世界市場は2030年までに14億米ドルに達する見込み

2024年に11億米ドルと推定される生検ガイダンスシステムの世界市場は、2024～2030年の分析期間においてCAGR 4.7%で成長し、2030年には14億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである定位誘導生検は、CAGR 5.5%を記録し、分析期間終了時には8億2,520万米ドルに達すると予測されています。超音波ガイド下生検セグメントの成長率は、分析期間中CAGR 4.2%と推定されます。

米国市場は推定2億9,490万米ドル、中国はCAGR8.7%で成長予測

米国の生検ガイダンスシステム市場は、2024年に2億9,490万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 8.7%で推移し、2030年には予測市場規模3億10万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.9%と3.7%と予測されています。欧州では、ドイツがCAGR 2.8%で成長すると予測されています。

世界の生検ガイダンスシステム市場- 主要動向と促進要因のまとめ

生検ガイダンスシステムが現代の診断に欠かせなくなった理由とは？

生検ガイダンスシステムは現代の医療診断において不可欠なツールとなっており、より高い精度、効率性、組織サンプリングの低侵襲性を実現しています。これらのシステムは、超音波、MRI、CTスキャン、ロボット支援ナビゲーションなどの高度な画像技術を用いて、針生検を正確に誘導します。がんやその他の慢性疾患の世界の負担が増加の一途をたどる中、高精度の生検技術に対する需要が急増しており、早期発見、治療計画、疾患モニタリングにとって生検ガイダンスシステムは極めて重要なものとなっています。

生検ガイダンスシステムは患者の不快感を軽減し、合併症発生率を低下させ、手技効率を高めるため、低侵襲手技へのシフトが生検ガイダンスシステムの採用をさらに促進しています。さらに、これらのシステムにおける人工知能（AI）とリアルタイム画像の統合は、診断精度と医師の信頼性を向上させています。個別化医療や標的治療が重視される中、生検ガイダンスシステムは分子や遺伝子のプロファイリングに必要な高品質の組織サンプルを提供する上で重要な役割を果たしています。ヘルスケアプロバイダーが早期発見と精密診断を優先する中、生検ガイダンスシステムの市場は今後数年で大きく拡大することが予想されます。

技術の進歩は生検ガイダンスシステムをどのように改善しているか？

画像処理、ロボット工学、AIの技術革新が生検ガイダンスシステムを変革し、より正確で効率的、ユーザーフレンドリーなものにしています。最も重要な進歩のひとつは、AIを活用した画像認識とリアルタイム分析の統合で、放射線科医や外科医がより高い精度で最適な生検部位を特定できるようになりました。AIを搭載した生検システムは、画像データをリアルタイムで解析し、針の配置に関する自動推奨を提供し、偽陰性のリスクを低減することができます。さらに、3D画像と拡張現実（AR）オーバーレイによって可視化機能が強化され、臨床医は複雑な解剖学的構造をかつてないほど明瞭にナビゲートできるようになりました。

生検ガイダンス技術におけるもう一つのブレークスルーは、優れた針制御、安定性、自動化を提供するロボット支援生検システムの開発です。これらのシステムは人為的ミスを最小限に抑え、小さな病変や到達困難な病変をより正確に標的にすることができます。さらに、エラストグラフィと造影超音波の進歩により、軟部組織の鑑別が向上し、組織が密集した環境でも悪性腫瘍をよりよく検出できるようになっています。また、ワイヤレスで持ち運び可能な生検ガイダンスシステムは、外来患者や遠隔地のヘルスケア施設で使用するための柔軟性を提供し、人気を集めています。このような技術革新が進化を続けるにつれ、生検ガイダンスシステムはますます効率的で正確なものとなり、幅広いヘルスケアプロバイダーが利用できるようになってきています。

生検ガイダンスシステムの成長を促進する市場動向は？

がんやその他の慢性疾患の世界の罹患率の増加は、生検ガイダンスシステム市場を牽引する最も重要な動向の一つです。世界のがん罹患率の上昇に伴い、早期かつ正確な診断がヘルスケアプロバイダーの主要な焦点となり、高度な生検ガイダンス技術の採用が進んでいます。さらに、画像誘導による低侵襲手術の人気の高まりは、患者の不快感を最小限に抑えながら高い精度を提供するシステムへの需要を加速させています。その結果、MRIガイド下および超音波ガイド下生検システムは、腫瘍学、乳房画像診断、インターベンショナルラジオロジーにおいて広く受け入れられるようになってきています。

市場を形成するもう1つの主要動向は、AI主導型ヘルスケアソリューションの拡大です。AIによる生検ガイダンスは、ワークフローの効率を改善し、生検の処置時間を短縮し、オペレーターへの依存を最小化することで、これらのシステムをより幅広い医療従事者が利用しやすくしています。さらに、リキッドバイオプシーや分子診断の台頭が従来の組織生検を補完しつつあり、画像診断とバイオマーカー検出を統合したハイブリッド生検ガイダンスソリューションの開発につながっています。遠隔医療や遠隔診断の採用が増加していることも、ポータブルでクラウド接続可能な生検ガイダンスシステムの需要を促進しており、複雑な症例に対するリアルタイムの診察や遠隔専門家ガイダンスを可能にしています。

生検ガイダンスシステム市場の将来を形作る主な成長促進要因とは？

生検ガイダンスシステム市場の成長は、がん罹患率の上昇、画像技術の進歩、精密医療への投資の増加など、いくつかの重要な要因によってもたらされます。主な成長要因の1つは、がんの早期発見・診断が重視されるようになり、スクリーニングプログラムや診断手順が増加していることです。世界中の政府やヘルスケア機関ががん啓発のイニシアチブを実施しており、診断精度を向上させるための先進的な生検ガイダンスシステムの採用をさらに後押ししています。

市場を形成するもう1つの重要な促進要因は、生検手技におけるAIとロボティクスの統合です。AI主導の意思決定支援ツールはより迅速で正確な診断を可能にし、ロボット支援システムは生検精度を向上させ、手技に関連する合併症を減少させています。さらに、外来患者や外来診療サービスの需要の高まりが、コンパクトで持ち運びが可能でコスト効率の高い生検ガイダンスシステムの必要性を高めています。ヘルスケアプロバイダーが患者の不快感を最小限に抑えながら診断効率を高めようとする中、先進的な生検ガイダンスシステムの採用は加速し、精密医療とがん診断の将来における重要なツールとして位置づけられると予想されます。

セグメント

製品タイプ（定位ガイド下生検、超音波ガイド下生検、MRIガイド下生検）、用途（脳生検用途、乳房生検用途、その他用途）、最終用途（病院最終用途、専門クリニック最終用途、診断センター最終用途、研究・学術機関最終用途）

調査対象企業の例

  • Argon Medical Devices, Inc.
  • Becton, Dickinson and Company（BD）
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical, LLC
  • Hologic, Inc.
  • INRAD, Inc.
  • Mammotome
  • PAJUNK（R）GmbH
  • Planmed Oy
  • Siemens Healthineers AG
  • Trivitron Healthcare

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP29608

Global Biopsy Guidance Systems Market to Reach US$1.4 Billion by 2030

The global market for Biopsy Guidance Systems estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Stereotactic Guided Biopsy, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$825.2 Million by the end of the analysis period. Growth in the Ultrasound Guided Biopsy segment is estimated at 4.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$294.9 Million While China is Forecast to Grow at 8.7% CAGR

The Biopsy Guidance Systems market in the U.S. is estimated at US$294.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$300.1 Million by the year 2030 trailing a CAGR of 8.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Biopsy Guidance Systems Market - Key Trends & Drivers Summarized

Why Are Biopsy Guidance Systems Becoming Essential in Modern Diagnostics?

Biopsy guidance systems have become an indispensable tool in modern medical diagnostics, enabling greater accuracy, efficiency, and minimally invasive procedures for tissue sampling. These systems use advanced imaging technologies, including ultrasound, MRI, CT scans, and robotic-assisted navigation, to guide needle biopsies with precision. As the global burden of cancer and other chronic diseases continues to rise, the demand for highly accurate biopsy techniques has surged, making biopsy guidance systems crucial for early detection, treatment planning, and disease monitoring.

The shift toward minimally invasive procedures is further driving the adoption of biopsy guidance systems, as they reduce patient discomfort, lower complication rates, and enhance procedural efficiency. Additionally, the integration of artificial intelligence (AI) and real-time imaging in these systems is improving diagnostic accuracy and physician confidence. With the growing emphasis on personalized medicine and targeted therapies, biopsy guidance systems are playing a critical role in providing high-quality tissue samples necessary for molecular and genetic profiling. As healthcare providers prioritize early detection and precision diagnostics, the market for biopsy guidance systems is expected to expand significantly in the coming years.

How Are Technological Advancements Improving Biopsy Guidance Systems?

Technological innovations in imaging, robotics, and AI are transforming biopsy guidance systems, making them more precise, efficient, and user-friendly. One of the most significant advancements is the integration of AI-powered image recognition and real-time analytics, which help radiologists and surgeons identify optimal biopsy sites with greater accuracy. AI-enhanced biopsy systems can analyze imaging data in real time, providing automated recommendations for needle placement and reducing the risk of false-negative results. Additionally, 3D imaging and augmented reality (AR) overlays are enhancing visualization capabilities, allowing clinicians to navigate complex anatomical structures with unprecedented clarity.

Another breakthrough in biopsy guidance technology is the development of robotic-assisted biopsy systems, which provide superior needle control, stability, and automation. These systems minimize human error and allow for more precise targeting of small or difficult-to-reach lesions. Additionally, advancements in elastography and contrast-enhanced ultrasound are improving soft tissue differentiation, enabling better detection of malignant tumors in dense tissue environments. Wireless and portable biopsy guidance systems are also gaining traction, offering greater flexibility for use in outpatient settings and remote healthcare facilities. As these technological innovations continue to evolve, biopsy guidance systems are becoming increasingly efficient, accurate, and accessible to a broader range of healthcare providers.

Which Market Trends Are Driving the Growth of Biopsy Guidance Systems?

The increasing global incidence of cancer and other chronic diseases is one of the most significant trends driving the biopsy guidance systems market. With cancer rates rising worldwide, early and accurate diagnosis has become a primary focus for healthcare providers, leading to greater adoption of advanced biopsy guidance technologies. Additionally, the growing popularity of image-guided minimally invasive procedures is accelerating demand for systems that offer high precision with minimal patient discomfort. As a result, MRI-guided and ultrasound-guided biopsy systems are gaining widespread acceptance in oncology, breast imaging, and interventional radiology.

Another key trend shaping the market is the expansion of AI-driven healthcare solutions. AI-assisted biopsy guidance is improving workflow efficiency, reducing biopsy procedure times, and minimizing operator dependency, making these systems more accessible to a wider range of medical professionals. Furthermore, the rise of liquid biopsy and molecular diagnostics is complementing traditional tissue biopsies, leading to the development of hybrid biopsy guidance solutions that integrate imaging with biomarker detection. The increasing adoption of telemedicine and remote diagnostics is also fueling demand for portable and cloud-connected biopsy guidance systems, enabling real-time consultation and remote expert guidance for complex cases.

What Are the Key Growth Drivers Shaping the Future of the Biopsy Guidance Systems Market?

The growth in the biopsy guidance systems market is driven by several key factors, including rising cancer prevalence, advancements in imaging technology, and increasing investments in precision medicine. One of the primary growth drivers is the growing emphasis on early cancer detection and diagnosis, which has led to increased screening programs and diagnostic procedures. Governments and healthcare organizations worldwide are implementing cancer awareness initiatives, further driving the adoption of advanced biopsy guidance systems to improve diagnostic accuracy.

Another crucial driver shaping the market is the integration of AI and robotics in biopsy procedures. AI-driven decision support tools are enabling faster and more accurate diagnoses, while robotic-assisted systems are improving biopsy precision and reducing procedure-related complications. Additionally, the growing demand for outpatient and ambulatory care services is driving the need for compact, portable, and cost-effective biopsy guidance systems. As healthcare providers seek to enhance diagnostic efficiency while minimizing patient discomfort, the adoption of advanced biopsy guidance systems is expected to accelerate, positioning them as a critical tool in the future of precision medicine and cancer diagnostics.

SCOPE OF STUDY:

The report analyzes the Biopsy Guidance Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Stereotactic Guided Biopsy, Ultrasound Guided Biopsy, MRI Guided Biopsy); Application (Brain Biopsy Application, Breast Biopsy Application, Other Applications); End-Use (Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use, Research and Academic Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 39 Featured) -

  • Argon Medical Devices, Inc.
  • Becton, Dickinson and Company (BD)
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical, LLC
  • Hologic, Inc.
  • INRAD, Inc.
  • Mammotome
  • PAJUNK(R) GmbH
  • Planmed Oy
  • Siemens Healthineers AG
  • Trivitron Healthcare

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Biopsy Guidance Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Burden of Cancer and Chronic Diseases Throws the Spotlight on Biopsy Guidance Systems for Accurate Diagnostics
    • Surge in Demand for Minimally Invasive Procedures Drives Adoption of Image-Guided Biopsy Technologies
    • Technological Advancements in Imaging Modalities Strengthen the Business Case for Real-Time Biopsy Guidance Systems
    • Shift Toward Early and Precision Diagnosis Expands Addressable Market Opportunity for Targeted Biopsy Devices
    • Integration of Ultrasound, CT, MRI, and Fusion Imaging Enhances Accuracy and Outcomes of Biopsy Procedures
    • Increasing Preference for Outpatient and Ambulatory Biopsy Settings Fuels Demand for Portable and User-Friendly Guidance Systems
    • Growth in Interventional Radiology and Image-Guided Oncology Spurs Wider Adoption of Navigation and Targeting Technologies
    • AI-Powered Imaging and Software-Driven Needle Guidance Systems Propel Innovation in Biopsy Procedures
    • Rising Demand for Organ-Specific and Site-Specific Biopsy Solutions Drives Market Segmentation and Customization
    • Improved Patient Comfort and Procedural Efficiency Strengthen the Shift from Manual to Automated Biopsy Guidance Systems
    • Advancements in Robotics and 3D Navigation Technologies Enhance Precision and Reduce Human Error in Biopsy Procedures
    • Increasing Adoption of Real-Time Tissue Characterization and Elastography Supports Intelligent Biopsy Targeting
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Biopsy Guidance Systems Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Biopsy Guidance Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Stereotactic Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Stereotactic Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Ultrasound Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Ultrasound Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for MRI Guided Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for MRI Guided Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Research and Academic Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Research and Academic Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Brain Biopsy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Brain Biopsy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Breast Biopsy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Breast Biopsy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 24: USA Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • CHINA
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 42: China Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Biopsy Guidance Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • FRANCE
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 82: Spain Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Spain 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 84: Spain Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Spain 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 88: Russia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Russia 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 90: Russia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Russia 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 94: Rest of Europe Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of Europe 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 96: Rest of Europe Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of Europe 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific 6-Year Perspective for Biopsy Guidance Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2025 & 2030
    • TABLE 100: Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Asia-Pacific 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 102: Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Asia-Pacific 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • AUSTRALIA
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 106: Australia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Australia 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 108: Australia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Australia 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • INDIA
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 112: India Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: India 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 114: India Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: India 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • SOUTH KOREA
    • TABLE 118: South Korea Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: South Korea 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 120: South Korea Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: South Korea 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 124: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of Asia-Pacific 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 126: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • LATIN AMERICA
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 130: Latin America Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 131: Latin America 6-Year Perspective for Biopsy Guidance Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2025 & 2030
    • TABLE 132: Latin America Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Latin America 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 136: Latin America Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Latin America 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • ARGENTINA
    • TABLE 138: Argentina Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Argentina 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 142: Argentina Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 143: Argentina 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • BRAZIL
    • TABLE 144: Brazil Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 145: Brazil 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 148: Brazil Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 149: Brazil 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • MEXICO
    • TABLE 150: Mexico Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 151: Mexico 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 154: Mexico Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 155: Mexico 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 156: Rest of Latin America Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 157: Rest of Latin America 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 160: Rest of Latin America Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 161: Rest of Latin America 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • MIDDLE EAST
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 162: Middle East Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 163: Middle East 6-Year Perspective for Biopsy Guidance Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 166: Middle East Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 167: Middle East 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 168: Middle East Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 169: Middle East 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 172: Iran Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 173: Iran 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 174: Iran Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 175: Iran 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 178: Israel Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 179: Israel 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 180: Israel Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 181: Israel 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 184: Saudi Arabia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 185: Saudi Arabia 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 186: Saudi Arabia Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 187: Saudi Arabia 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 190: UAE Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 191: UAE 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 192: UAE Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 193: UAE 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 196: Rest of Middle East Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 197: Rest of Middle East 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 198: Rest of Middle East Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 199: Rest of Middle East 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030
  • AFRICA
    • Biopsy Guidance Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Product Type - Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa 6-Year Perspective for Biopsy Guidance Systems by Product Type - Percentage Breakdown of Value Sales for Stereotactic Guided Biopsy, Ultrasound Guided Biopsy and MRI Guided Biopsy for the Years 2025 & 2030
    • TABLE 202: Africa Recent Past, Current & Future Analysis for Biopsy Guidance Systems by End-Use - Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 203: Africa 6-Year Perspective for Biopsy Guidance Systems by End-Use - Percentage Breakdown of Value Sales for Research and Academic Institutes End-Use, Hospitals End-Use, Specialty Clinics End-Use and Diagnostic Centers End-Use for the Years 2025 & 2030
    • TABLE 204: Africa Recent Past, Current & Future Analysis for Biopsy Guidance Systems by Application - Brain Biopsy Application, Breast Biopsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 205: Africa 6-Year Perspective for Biopsy Guidance Systems by Application - Percentage Breakdown of Value Sales for Brain Biopsy Application, Breast Biopsy Application and Other Applications for the Years 2025 & 2030

IV. COMPETITION